Anne-Laure Sberna

European Association for the Study of the Liver (<scp>EASL</scp>), European Association for the Study of Diabetes (<scp>EASD</scp>) and European Association for the Study of Obesity (<scp>EASO</scp>) clinical practice recommendations for the management of non‐alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes

Anne-Laure Sberna, Benjamin Bouillet, Alexia Rouland et al. · Diabetic Medicine · 2017 · 319 citations

Medicine, Endocrinology, Internal Medicine +17

Induction of Transglutaminase 2 by a Liver X Receptor/Retinoic Acid Receptor α Pathway Increases the Clearance of Apoptotic Cells by Human Macrophages

Cédric Rébé, Magalie Raveneau, Angélique Chevriaux et al. · Circulation Research · 2009 · 98 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus

Bruno Vergès, Laurence Duvillard, Jean-Paul Paı̈s de Barros et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2018 · 71 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Effect of Plasma Phospholipid Transfer Protein Deficiency on Lethal Endotoxemia in Mice

Thomas Gautier, Alexis Klein, Valérie Deckert et al. · Journal of Biological Chemistry · 2008 · 64 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +14

Constitutive Androstane Receptor Activation Decreases Plasma Apolipoprotein B–Containing Lipoproteins and Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice

Anne-Laure Sberna, Mahfoud Assem, Rui Xiao et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2011 · 36 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17